Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-09

Clinical Trial Update: Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating combination therapy with interferon, interleukin-2, and hepatitis B vaccine in chronic hepatitis B patients has completed. Sponsor Tong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatitis B vaccine (Hepatitis B vaccine)
  • Interferon (interferon)
  • Interleukin-2 (interleukin-2)

Snippet

Sponsor: Tongji Hospital | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED